Sperri, a Canadian organic and allergen-free plant-based meal replacement beverage, announced a new investment to support its expansion into the United States and drive new product innovation led by investor Nàdarra Ventures and supported by Invest Nova Scotia.

Sperri, a Halifax-based company, is at the forefront of disrupting the food and beverage industry, driven by the philosophy that food is medicine. Sperri co-founders, Gregg Curwin, President & CEO of Novagevity, and Dr. Mary Lynch, physician and pain management specialist, collaborated to blend science and innovation to meet the nutrition needs of consumers.

CHECK OUT MORE FOOD & BEVERAGE INDUSTRY NEWS

Dr. Lynch observed that many of her patients required meal replacements to access proper nutrition, but struggled to tolerate existing options due to high levels of processed sugars, dairy, gluten and soy protein. Collaborating with Curwin, an experienced entrepreneur, Sperri was created with the mission of helping people get well and stay well.

“Our products are grounded in scientific research leading to effective medical nutrition, and the ethos of Sperri is to inspire change within our conventional healthcare systems,” says Curwin. “We are rooted in the belief that food is medicine, and that not only Nova Scotians, but everyone throughout North America, needs that more than ever. Sperri products are designed to be accessible, affordable, and effective, ultimately becoming a major benefit to Primary Care treatment, in a time of critical need to relieve pressure from our healthcare system.”

Born out of the Sobey School of Business at Saint Mary’s University in Halifax, Sperri has deep roots throughout Nova Scotia, with the beverage’s name sake inspired by Sperry Beach, located on the South Shore of the province. Sperri has received overwhelming local support, with independent NS investors, industry executives, and members of the pharmaceutical industry also participating in the raise, alongside Invest Nova Scotia and Nàdarra Ventures.

Nàdarra Ventures, a Canadian early-stage venture capital fund focused on accelerating sustainable biotechnology in the areas of agriculture, food, and materials, is the lead investor for Sperri’s launch into the US Market.

Invest Nova Scotia, the province’s business development agency, is also supporting Sperri’s expansion into the US Market alongside lead investor, Nàdarra Ventures. Invest Nova Scotia provides capital, export services, and facilities to help start-ups succeed, like The Labs at Invest Nova Scotia, where Novagevity operates.